EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

CRISPR-based genetic screens in human pluripotent stem cells derived neurons and brain organoids

Yu Guo, Xinyu Zhao

Cell and Tissue Research · 2025

DOI: 10.1007/s00441-024-03934-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell and Tissue Research, 2025. Verfasst von Yu Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA. Hauptthemen laut MEDLINE: Organoids, Neurons, Brain, Pluripotent Stem Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Child Health and Human Development, NIMH NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent large-scale genome-wide association and single-cell RNA sequencing (scRNA-seq) studies have uncovered disease-associated genetic risk factors and cell type-specific genetic alterations. However, our understanding of how these genetic variants cause diseases and the underlying mechanisms remains largely unknown. Functional genomics screens using CRISPR-based technologies offer an effective tool for studying genes relevant to disease phenotypes. Here, we summarize recent CRISPR-based functional genomics screen approaches applied to human pluripotent stem cell (hPSC)-derived neurons and brain organoids. These screens have identified genes crucial for neurogenesis, neuronal survival, morphological development, and migration. Combining CRISPR-based genetic screens with scRNA-seq, researchers have revealed downstream genes and cellular pathways impacted by these genetic variants in human neural cells, providing new insights into the pathogenesis of neurodevelopmental disorders, such as microcephaly and autism spectrum disorders. Finally, we discuss current challenges and future directions for using CRISPR-based screens in furthering our understanding of neurological diseases and developing potential therapeutic strategies. Despite challenges, CRISPR-based screens have enormous potential for advancing the therapeutic development of many diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeuronsBrainPluripotent Stem CellsCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsGenetic TestingHumansNeurogenesis

Stichwörter der Autor:innen

CRISPRGenetic screensNeurological diseasesNeuronsOrganoids

Autor:innen und Institutionen

  • Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA. xinyu.zhao@wisc.edu.
  • Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA. xinyu.zhao@wisc.edu.

Förderung

  • National Institute of Child Health and Human Development
  • NIMH NIH HHS
  • NICHD NIH HHS
  • NINDS NIH HHS
  • Warren Alper foundation
  • National Institute of Mental Health

Zitieren

APA

Guo, Y., & Zhao, X. (2025). CRISPR-based genetic screens in human pluripotent stem cells derived neurons and brain organoids. Cell and Tissue Research. https://doi.org/10.1007/s00441-024-03934-2

Vancouver

Guo Y, Zhao X. CRISPR-based genetic screens in human pluripotent stem cells derived neurons and brain organoids. Cell and Tissue Research. 2025. doi:10.1007/s00441-024-03934-2

BibTeX
@article{Guo2025,
  author = {Guo, Yu and Zhao, Xinyu},
  title = {CRISPR-based genetic screens in human pluripotent stem cells derived neurons and brain organoids},
  journal = {Cell and Tissue Research},
  year = {2025},
  doi = {10.1007/s00441-024-03934-2}
}
Kostenlos starten →